Stocks
Novo Nordisk (NVO) OPEX US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OPEX | 58 498 000 000 | 73 697 000 000 | 93 922 000 000 | 117 542 000 000 | 122 618 000 000 | 119 819 000 000 | |||
| Changes by years, y/y, % | +13% | +26% | +27% | +25% | +4% | +18.8% | |||
Novo Nordisk. OPEX
Novo Nordisk. OPEX, changes, %
Novo Nordisk. OPEX, sum by quarters
Novo Nordisk (NVO) OPEX US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| OPEX | 26 406 000 000 | 30 562 000 000 | 33 390 000 000 | 32 260 000 000 | 23 607 000 000 | 119 819 000 000 | ||
| Changes by years, y/y, % | +12% | -4% | +28% | -10% | -11% | |||
| Changes by quarters, q/q, % | -26% | +16% | +9% | -3% | -27% | |||
